PharmEasy Parent API Holdings’ FY26 Loss Declines 67% YoY To ₹520 Cr

What happened

PharmEasy Parent API (the interface one piece of software uses to talk to another) Holdings’ FY26 Loss Declines 67% YoY To ₹520 Cr, according to Inc42. PharmEasy parent API Holdings narrowed its consolidated net loss by 67% to ₹520 Cr in the fiscal year ended March 2026 (FY26) from ₹1,572 Cr in the previous fiscal, with its operating revenue growing 12.7% YoY to ₹6,618.5 Cr. The company attributed the improvement to its focus on customer experience, higher-value profitable segments, capacity utilisation, increasing wallet share and leveraging digital capabilities.

In its FY26 annual report, API Holdings said it improved margins by focusing on higher-margin products, particularly its private label brands, and optimising discounts in its B2R business. Including other income of ₹70.8 Cr, the company’s total revenue stood at ₹6,689.2 Cr for FY26.

However, it continued to report a loss before tax of ₹456.1 Cr. In the first quarter of FY27, API Holdings reported a 10% YoY increase in revenue to ₹1,754 Cr while EBITDA rose to ₹39.3 Cr.